Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1056/NEJMicm2401200 | DOI Listing |
Cureus
November 2024
Ophthalmology, Hiroshima University, Hiroshima, JPN.
Cytotoxic anticancer drug solution eye drops can hinder the cell division of corneal basal cell division and corneal limbal epithelial stem cell migration. We discuss a case involving recurrent corneal epithelial erosions induced by 1% 5-fluorouracil (5-FU) solution eye drops. A 68-year-old male with conjunctival papilloma on his left eye underwent recurrences three times and additional tumor excision.
View Article and Find Full Text PDFArch Soc Esp Oftalmol (Engl Ed)
December 2024
Servicio de Oftalmología, Hospital Universitario La Paz, Madrid, Spain.
Purpose: To communicate the results and complications in a series of 17 proximal lacrimal pathway obstructions (PLPO) operated by conjunctivo-rhinostomy (CR) with Métaireau tube implantation.
Methods: Retrospective descriptive study including 16 patients (17 PLPO) operated with CR between April 2010 and June 2017. Surgeries were performed under general anesthesia.
Ophthalmol Sci
September 2024
Ophthalmology Consult Services Section, National Eye Institute, NIH, Bethesda, Maryland.
Objective: To investigate the effects of oral baricitinib on ocular surface disease (OSD) in patients with chronic graft-versus-host disease (cGVHD).
Design: Prospective phase 1 to 2 single institution trial.
Subjects: Eighteen patients with ocular graft-versus-host-disease (oGVHD) and systemic steroid-refractory cGVHD.
Cornea
November 2024
Royal Victorian Eye and Ear Hospital, East Melbourne, Australia.
Purpose: We report a unique case of significant human papillomavirus-associated conjunctival papillomas and severe corneal ulceration leading to corneal perforation in a patient treated with dupilumab for atopic dermatitis.
Methods: This study is a case report and literature review of severe corneal side effects related to dupilumab.
Results: A 27-year-old man with severe atopic dermatitis and no ocular history was administered dupilumab 300 mg via subcutaneous injections every 2 weeks with an excellent response.
Can J Ophthalmol
August 2024
Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, FL. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!